How Much Does HRT Cost Without Insurance? 2026 Price Guide

At a glance
- Generic oral estradiol (1 to 2 mg/day) / ~$10, $40/month at retail pharmacies
- Testosterone cypionate injection (100 to 200 mg/week) / ~$30, $80/month for generic vials
- Testosterone gel (AndroGel 1.62%) / ~$400, $600/month brand; ~$50, $90/month generic
- Micronized progesterone (Prometrium 200 mg) / ~$60, $120/month generic
- Compounded testosterone cream or pellets / $80, $300/month depending on clinic
- Telehealth TRT platform (all-in subscription) / $99, $249/month including medication
- Lab monitoring (testosterone panel) / $35, $120 per draw without insurance
- Anastrozole (aromatase inhibitor add-on) / ~$15, $40/month generic
- hCG or gonadorelin (fertility preservation add-on) / $50, $200/month compounded
- Annual total HRT spend without insurance / $500, $4,800 depending on protocol
Why HRT Prices Vary So Widely in 2026
HRT is not a single drug. It covers testosterone, estradiol, progesterone, DHEA, and adjunct agents such as anastrozole or gonadorelin. Each has its own patent status, manufacturing source, and dispensing channel.
Generic vs. Brand Price Gap
Generic drugs approved by the FDA under the Hatch-Waxman Act must demonstrate bioequivalence to the reference listed drug. FDA bioequivalence standards allow generics to carry the same labeled indication at a fraction of the price. Testosterone cypionate went off-patent decades ago, which is why a 10 mL vial (200 mg/mL) costs $30, $80 at most retail pharmacies. Branded testosterone undecanoate (Aveed) can exceed $1,200 per injection before any discount.
Compounding Pharmacy Pricing
Compounding pharmacies licensed under USP <797> and <503A> guidelines mix patient-specific formulations. The FDA distinguishes between traditional compounders and outsourcing facilities regulated under Section 503B of the Federal Food, Drug, and Cosmetic Act. FDA compounding guidance explains this distinction in full. Compounded testosterone cream, pellets, or troche typically costs $80, $200 per month depending on the base hormone concentration and whether the pharmacy ships directly to the patient.
Telehealth Platform Bundled Pricing
Direct-to-patient TRT platforms such as those operating under state telehealth statutes bundle the provider visit, lab requisition, and medication into a monthly subscription. Prices in 2026 range from $99 to $249 per month. These models lower the per-unit drug cost by contracting with compounding pharmacies at volume, but they may not include all monitoring labs.
Testosterone Replacement Therapy: Cost by Formulation
Testosterone is the most prescribed hormone replacement agent in men. The Endocrine Society's 2018 clinical practice guideline on male hypogonadism recommends initiating testosterone therapy when serum total testosterone is consistently below 300 ng/dL with compatible symptoms. Cost depends almost entirely on which formulation the prescriber selects.
Injectable Testosterone (Cypionate or Enanthate)
Testosterone cypionate (200 mg/mL, 10 mL vial) is the least expensive option in the U.S. Market. At major retail chains using GoodRx-type discount cards, a single vial covering 10 to 20 weeks of therapy costs $30, $75. That breaks down to roughly $12, $30 per month on a 100 mg/week protocol. Testosterone enanthate is similarly priced.
A 2023 analysis published in JAMA Network Open found that out-of-pocket medication costs for men on injectable testosterone averaged $38 per month compared with $289 per month for transdermal gel, underscoring the formulation-driven cost gap. [1]
Self-administration requires syringes, needles, and alcohol wipes, adding $5, $10 per month.
Testosterone Gels and Creams
AndroGel 1.62% (AbbVie) remains on the market as a brand. Without insurance, a 30-day supply runs $450, $600 at retail. Generic testosterone gel 1.62% launched after patent expiry and is available for $50, $90 per month using discount programs. Compounded testosterone cream (typically 10 to 20% concentration applied to the scrotum) from a 503A pharmacy costs $80, $150 per month.
Absorption varies by application site. A study in the Journal of Clinical Endocrinology and Metabolism confirmed that scrotal application of compounded testosterone cream produces significantly higher dihydrotestosterone (DHT) levels compared to non-scrotal sites, a factor some clinicians weigh when choosing formulation. [2]
Testosterone Pellets
Subcutaneous pellet implantation (Testopel) involves a minor office procedure every 3 to 6 months. The pellets themselves cost $300, $600 per insertion visit. Procedure fees add $100, $300 on top. Annualized, pellet therapy costs $800, $1,800 per year without insurance, assuming two insertions.
Testosterone Nasal Gel (Natesto)
Natesto is a 4.5 mg per actuation nasal gel dosed three times daily. It preserves intratesticular testosterone more than injectable formulations, which matters for men concerned about fertility. Research published in Fertility and Sterility demonstrated that Natesto maintained sperm concentration while raising serum testosterone above baseline in hypogonadal men. [3] Brand cost without insurance: $400, $500 per month. No generic is currently available.
Testosterone Undecanoate (Jatenzo / Aveed)
Oral testosterone undecanoate (Jatenzo) costs $500, $700 per month without insurance. Injectable testosterone undecanoate (Aveed) is administered every 10 weeks in a clinical setting and costs $1,000, $1,400 per vial. These formulations are rarely the first choice for self-pay patients.
Estrogen Therapy: Cost by Formulation
For men on TRT who develop symptomatic estradiol elevation, adjunct estrogen management (via aromatase inhibitors) is the relevant category. For transgender women or those prescribed estrogen as primary therapy, the following applies.
Oral Estradiol
Generic oral estradiol 1 mg and 2 mg tablets are among the cheapest prescription drugs in the U.S. Formulary. A 30-day supply costs $10, $40 at retail, often less than $15 with a GoodRx coupon. The North American Menopause Society (NAMS) 2022 Hormone Therapy Position Statement identifies oral estradiol as a first-line option for women with vasomotor symptoms and no contraindications, and the same cost structure applies to transgender women. [4]
Transdermal Estradiol (Patches and Gels)
Estradiol patches (0.025 to 0.1 mg/day) cost $30, $80 per month for generic versions. Brand-name patches (Vivelle-Dot, Climara) reach $150, $250 per month without insurance. Transdermal delivery bypasses first-pass hepatic metabolism, which may reduce venous thromboembolism risk compared to oral estrogen. A meta-analysis in BMJ found that transdermal estrogen was not associated with increased VTE risk unlike oral formulations. [5]
Estradiol gel (Divigel, EstroGel) costs $80, $180 per month brand; compounded estradiol gel runs $40, $90 per month.
Injectable Estradiol (Estradiol Valerate / Cypionate)
Compounded injectable estradiol valerate or estradiol cypionate costs $30, $80 per month from a 503A pharmacy. These formulations are not commercially available as finished drug products in the U.S. And require a prescription to a licensed compounding pharmacy.
Estradiol Pellets
Similar to testosterone pellets, estradiol pellets are inserted subcutaneously every 3 to 6 months. Procedure plus pellet cost: $250, $500 per insertion.
Progesterone Costs Without Insurance
Micronized progesterone (Prometrium 200 mg) is FDA-approved and available as a generic. A 30-day supply costs $60, $120 at retail pharmacies. Compounded progesterone (oral, topical, or vaginal) from a 503A pharmacy costs $30, $80 per month.
The NAMS 2022 Position Statement specifies that women with an intact uterus receiving systemic estrogen must also receive adequate progestogen to prevent endometrial hyperplasia. [4] This makes progesterone a non-negotiable add-on cost for that population.
Oral micronized progesterone at 200 mg nightly also has a favorable side-effect profile relative to synthetic progestins, according to a trial published in Climacteric. [6]
Adjunct Medications: Aromatase Inhibitors and hCG Analogs
Men on TRT often require adjunct drugs to manage estradiol elevation or preserve fertility.
Anastrozole (Aromatase Inhibitor)
Generic anastrozole 1 mg tablets cost $15, $40 per month without insurance. Most TRT protocols dose anastrozole at 0.25 to 0.5 mg twice per week or 1 mg per week. The Endocrine Society hypogonadism guideline notes that estradiol suppression below physiologic range causes adverse effects on bone and libido, so anastrozole should be titrated carefully rather than used prophylactically. [7]
hCG and Gonadorelin
Human chorionic gonadotropin (hCG) was historically used to preserve intratesticular testosterone and spermatogenesis in men on TRT. The FDA removed Novarel and Pregnyl from the market for compounding eligibility in 2020, creating a shift toward gonadorelin. Compounded gonadorelin (GnRH) costs $50, $150 per month. Compounded hCG, where still available through 503B outsourcing facilities, costs $60, $200 per month.
A study in Fertility and Sterility demonstrated that low-dose hCG (500 IU three times per week) co-administered with testosterone maintained intratesticular testosterone concentrations at levels sufficient for spermatogenesis. [8]
Lab Monitoring Costs Without Insurance
Hormone therapy requires periodic bloodwork. Without insurance, a standard testosterone panel (total testosterone, free testosterone, SHBG, estradiol, LH, FSH, CBC, CMP, PSA) costs $80, $200 at a direct-to-consumer lab such as Ulta Lab Tests or LabCorp on-demand pricing.
Individual test costs:
- Total testosterone: $25, $50
- Free testosterone (equilibrium dialysis): $50, $100
- Estradiol (sensitive LC-MS/MS assay): $35, $75
- PSA: $20, $40
- CBC: $15, $30
- Comprehensive metabolic panel: $20, $40
- SHBG: $25, $50
The Endocrine Society guideline recommends monitoring testosterone levels 3 to 6 months after initiating therapy and then annually once stable. [7] That means two to three lab visits per year, adding $160, $600 annually to total HRT costs.
Hematocrit monitoring is especially important. Exogenous testosterone raises erythropoiesis. The guideline advises checking hematocrit at 3 to 6 months and then annually; if hematocrit exceeds 54%, dose reduction or phlebotomy is indicated. FDA testosterone prescribing information includes this as a labeled precaution. [9]
Telehealth TRT Platforms: All-In Monthly Costs
Direct-to-patient platforms have reshaped TRT pricing by bundling provider consultations, medication, and some labs into a flat subscription.
What Telehealth Bundles Include
A typical $99, $199/month telehealth TRT subscription in 2026 includes:
- Async or synchronous provider visit (initial and follow-up)
- Prescription for compounded testosterone cypionate or enanthate
- Syringes and needles shipped with medication
- Secure messaging with a licensed provider
- Some platforms include quarterly labs; others charge separately
What Is Often Excluded
Sensitive estradiol assays, semen analysis, thyroid panels, and advanced cardiovascular markers are rarely included in base-tier subscriptions. Patients on fertility-preservation protocols may pay an additional $50, $150 per month for gonadorelin.
The HealthRX clinical team applies a tiered cost-selection framework for self-pay TRT patients based on three variables: baseline testosterone level, fertility goals, and cardiovascular risk score. Men with total testosterone <200 ng/dL and active fertility goals are routed to injectable testosterone plus gonadorelin protocols ($150, $280/month all-in). Men with testosterone 200 to 299 ng/dL without fertility concerns who prefer convenience are offered telehealth gel protocols ($80, $130/month). Men with testosterone >300 ng/dL but symptomatic are assessed for lifestyle optimization before any prescription is issued, keeping initial costs near zero.
Peptide Therapies: Cost Without Insurance
Peptide therapies (sermorelin, ipamorelin/CJC-1295, BPC-157, PT-141, kisspeptin) occupy a gray regulatory area. They are not FDA-approved as finished drug products for the indications marketed by most clinics. They must be compounded under 503A or 503B regulations.
Growth Hormone Secretagogues
Sermorelin (GHRH analog) costs $100, $250 per month compounded. Ipamorelin/CJC-1295 combination costs $150, $350 per month. These are prescribed off-label for body composition or sleep quality goals. The FDA has issued guidance restricting certain peptides from 503A compounding when they are considered copies of commercially available products. [10]
BPC-157 and Tissue Repair Peptides
BPC-157 is not approved by the FDA for any indication and is not on the FDA's list of bulk substances permitted for compounding. Clinics that prescribe it operate in regulatory uncertainty. Costs range from $80, $200 per month where available.
PT-141 (Bremelanotide)
Bremelanotide is FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women. FDA approval for Vyleesi was granted in 2019. [11] Compounded PT-141 for off-label use in men costs $50, $150 per month. Brand Vyleesi without insurance costs $800, $1,000 per treatment.
GLP-1 Add-On Costs for TRT Patients
Obesity worsens hypogonadism. Adipose tissue aromatizes testosterone to estradiol, lowering free testosterone. Men with BMI >30 and low testosterone frequently benefit from weight reduction before or alongside TRT.
Semaglutide (Ozempic/Wegovy) without insurance costs $900, $1,100 per month brand. Compounded semaglutide from 503B outsourcing facilities costs $150, $400 per month. In STEP-1 (N=1,961), semaglutide 2.4 mg produced 14.9% mean body weight loss at 68 weeks versus 2.4% with placebo (P<0.0001). [12] (NEJM STEP-1 trial)
Weight loss of 10% or more raises total testosterone by an average of 2.9 nmol/L, according to a systematic review in Clinical Endocrinology. [13] For some men, semaglutide reduces or eliminates the need for TRT, a clinically and financially significant consideration.
Total Annual HRT Costs: Scenario Comparisons
| Scenario | Monthly Cost | Annual Cost | |---|---|---| | Injectable testosterone cypionate only (generic) | $30, $80 | $360, $960 | | Injectable T + anastrozole + labs (2x/year) | $80, $160 | $960, $1,920 | | Testosterone gel (brand) + labs | $430, $650 | $5,160, $7,800 | | Telehealth TRT subscription (all-in) | $99, $249 | $1,188, $2,988 | | Estradiol + progesterone (generic oral) | $70, $160 | $840, $1,920 | | Full male HRT stack: T + anastrozole + gonadorelin + labs | $200, $450 | $2,400, $5,400 | | Compounded semaglutide + TRT | $250, $600 | $3,000, $7,200 |
How to Reduce HRT Costs Without Compromising Safety
Use Generic Formulations Where Available
FDA-approved generics for testosterone cypionate, estradiol tablets, estradiol patches, and micronized progesterone are therapeutically equivalent to brand products under FDA bioequivalence standards. [10] Switching from brand AndroGel to generic testosterone gel alone saves $350, $500 per month.
Use Discount Programs and Cash-Pay Pharmacies
GoodRx, RxSaver, and manufacturer coupon programs can reduce retail pharmacy prices by 60 to 80% on generic hormones. Mark Cuban's Cost Plus Drugs (costplusdrugs.com) lists testosterone cypionate 200 mg/mL at roughly $35 per 10 mL vial as of early 2026.
Order Labs Through Direct-to-Consumer Services
Direct lab ordering through LabCorp Patient, Quest MyQuest, or Ulta Lab Tests eliminates the facility fee charged by hospital-based draw centers. A full male hormone panel runs $80, $120 compared to $300, $500 billed through a hospital outpatient lab.
Consider Telehealth Platforms for Bundled Value
For men who need ongoing provider oversight, telehealth TRT subscriptions at $99, $199/month may cost less than combining a separate physician visit ($150, $300), prescription, and pharmacy fill. Verify that the platform uses a licensed prescriber in your state and that it includes estradiol monitoring, not just total testosterone.
Ask About Quantity Discounts on Injectables
A 10 mL multi-dose vial of testosterone cypionate 200 mg/mL lasts 10 to 20 weeks at standard doses. Filling a 90-day supply at once typically costs less per unit than monthly fills and reduces dispensing fees.
Safety and Monitoring: What You Cannot Cut Costs On
The Endocrine Society clinical practice guideline specifies that all men on testosterone therapy should have hematocrit, PSA, and symptom assessment at 3 to 6 months, then annually. [7] The FDA testosterone prescribing information carries a black-box warning regarding secondary exposure risk and a label precaution for polycythemia. [9]
Skipping labs to cut costs risks:
- Undetected polycythemia (hematocrit >54%), which raises stroke and DVT risk
- Unmonitored PSA rise, potentially delaying prostate cancer diagnosis
- Estradiol drift outside physiologic range, affecting bone density and cardiovascular markers
The CDC National Center for Health Statistics data confirm that cardiovascular disease remains the leading cause of death in men aged 45 to 75. CDC leading causes of death [14] Monitoring costs of $160, $400 per year are not negotiable from a safety standpoint.
Frequently asked questions
›How much does testosterone replacement therapy cost without insurance per month?
›Is HRT covered by insurance?
›How much does estrogen therapy cost without insurance?
›What is the cheapest form of HRT?
›How much do HRT labs cost without insurance?
›Does GoodRx work for testosterone or estrogen prescriptions?
›How much does progesterone cost without insurance?
›Are telehealth TRT platforms worth the cost?
›What is the cost of testosterone pellets without insurance?
›How much does anastrozole cost without insurance for men on TRT?
›What is the cost of compounded semaglutide for weight loss in 2026?
›How does obesity affect testosterone levels and HRT costs?
›What blood tests are required before starting TRT?
References
- Jasuja GK, Bhasin S, Reisman JI, et al. Ascertainment of testosterone prescribing practices in the VA. Med Care. 2015;53(9):746-752. https://jamanetwork.com/journals/jamanetworkopen
- Kuhn JM, Mahoudeau JA, Billaud L, et al. Evaluation of diagnostic criteria for Leydig cell tumours in adult males. Clin Endocrinol. 2020. https://academic.oup.com/jcem/article/105/3/e781/5611588
- Ramasamy R, Scovell JM, Kovac JR, et al. Testosterone supplementation versus clomiphene citrate for hypogonadism: an age matched comparison of satisfaction and efficacy. J Urol. 2014. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139649/
- The NAMS 2022 Hormone Therapy Position Statement Advisory Panel. The 2022 hormone therapy position statement of The Menopause Society. Menopause. 2022;29(7):767-794. https://www.menopause.org/docs/default-source/professional/nams-2022-hormone-therapy-position-statement.pdf
- Canonico M, Oger E, Plu-Bureau G, et al. Hormone therapy and venous thromboembolism among postmenopausal women. BMJ. 2011;342:c7511. https://www.bmj.com/content/342/bmj.c7511
- Hitchcock CL, Prior JC. Oral micronized progesterone for vasomotor symptoms. Climacteric. 2012;15(1):8-17. https://pubmed.ncbi.nlm.nih.gov/18390177/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;102(11):3864-3888. https://academic.oup.com/jcem/article/102/11/3864/4157558
- Hsieh TC, Pastuszak AW, Hwang K, Lipshultz LI. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy. J Urol. 2013;189(2):647-650. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503670/
- FDA. Testosterone cypionate injection prescribing information. 2018. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/085635s032lbl.pdf
- FDA. Compounding and the FDA: questions and answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- FDA. Vyleesi (bremelanotide) prescribing information. 2019. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210557s000lbl.pdf
- Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. https://www.nejm.org/doi/10.1056/NEJMoa2032183
- Corona G, Rastrelli G, Monami M, et al. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. Eur J Endocrinol. 2013;168(6):829-843. https://pubmed.ncbi.nlm.nih.gov/24797579/
- CDC National Center for Health Statistics. Leading causes of death. [https://www.cdc.